Risk of Incident Diabetes Associated with Dose and Duration of Oral Glucocorticoid Therapy in Patients with Rheumatoid Arthritis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk of Incident Diabetes Associated with Dose and Duration of Oral Glucocorticoid Therapy in Patients with Rheumatoid Arthritis

Published:2015-12 Issue: Volume: Page:n/a-n/a
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Movahedi Mohammad¹,Beauchamp Marie-Eve²,Abrahamowicz Michal²³,Ray David W.⁴,Michaud Kaleb⁵⁶,Pedro Sofia⁵,Dixon William G.¹

Affiliation:

1. Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, The University of Manchester; UK

2. Division of Clinical Epidemiology; McGill University Health Centre; Canada

3. Department of Epidemiology, Biostatistics, and Occupational Health; McGill University; Canada

4. Centre of Endocrinology and Diabetes, Institute of Human Development, Manchester Academic Health Science Centre; The University of Manchester; UK

5. National Data Bank for Rheumatic Diseases; Wichita KS USA

6. University of Nebraska Medical Center; Omaha NE USA

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of immunosuppressive protocols used in AAV gene therapy for monogenic disorders;Molecular Therapy;2024-07

2. Management of Rheumatoid Arthritis in Primary Care: A Scoping Review;International Journal of Environmental Research and Public Health;2024-05-22

3. Rheumatoid arthritis—recent advances in pathogenesis and the anti-inflammatory effect of plant-derived COX inhibitors;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-02-15

4. Integrating Nanotechnological Advancements of Disease-Modifying Anti-Rheumatic Drugs into Rheumatoid Arthritis Management;Pharmaceuticals;2024-02-14

5. Assessing cumulative effects of medication use: New insights and new challenges;Pharmacoepidemiology and Drug Safety;2023-12-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3